The effect of consuming instant black tea on postprandial plasma glucose and insulin concentrations in healthy humans.
OBJECTIVE
To determine the effects of black tea on postprandial plasma glucose and insulin concentrations in healthy humans in response to an oral glucose load.


METHODS
A four-way randomised, crossover trial was designed in which 16 healthy fasted subjects would consume 75g of glucose in either 250ml of water (control), 250ml of water plus 0.052g of caffeine (positive control) or 250 ml of water plus 1.0g or 3.0g of instant black tea. Blood samples were collected at fasting and at 30min intervals for 150min from commencement of drink ingestion. Glucose and insulin concentrations were measured using standard methodology. The tea was chemically characterised using colorimetric and HPLC methods.


RESULTS
Chemical analysis showed that the tea was rich in polyphenolic compounds (total, 350mg/g). Results from only 3 treatment arms are reported because the 3.0g tea drink caused gastrointestinal symptoms. Plasma glucose concentrations <60min in response to the drinks were similar, but were significantly reduced at 120min (P<0.01), following ingestion of the 1.0g tea drink, relative to the control and caffeine drinks. Tea consumption resulted in elevated insulin concentrations compared with the control and caffeine drinks at 90min (P<0.01) and compared with caffeine drink alone at 150min (P<0.01).


CONCLUSIONS
The 1.0g tea drink reduced the late phase plasma glucose response in healthy humans with a corresponding increase in insulin. This may indicate that the attenuation in postprandial glycemia was achieved as a result of an elevated insulin response following stimulation of pancreatic beta-cells. This effect may be attributable to the presence of phenolic compounds in the tea.
Bryans
Judith A
JA
King's College London, School of Biomedical and Health Sciences, Nutritional Sciences Division, Biopolymers Group, Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NN, United Kingdom.
Judd
Patricia A
PA
Ellis
Peter R
PR
D000328:Adult; D019540:Area Under Curve; D001628:Beverages; D001786:Blood Glucose / Q000378:metabolism*; D002110:Caffeine / Q000008:administration & dosage / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003124:Colorimetry / Q000379:methods; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D005951:Glucose Tolerance Test / Q000379:methods; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D010636:Phenols / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D059808:Polyphenols; D019518:Postprandial Period; D013662:Tea / Q000737:chemistry
D001786:Blood Glucose; D005419:Flavonoids; D007328:Insulin; D010636:Phenols; D059808:Polyphenols; D013662:Tea; D002110:Caffeine